高级检索
当前位置: 首页 > 详情页

SP1-induced upregulation of lncRNA CTBP1-AS2 accelerates the hepatocellular carcinoma tumorigenesis through targeting CEP55 via sponging miR-195-5p

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Chinese Peoples Liberat Army Gen Hosp, Med Sch Chinese PLA, Dept Intervent Ultrasound, 28 Fuzing Rd, Beijing 100853, Peoples R China [2]Hebei Univ, Affiliated Hosp, Dept Ultrasound, Baoding 071000, Hebei, Peoples R China [3]Hebei Univ, Affiliated Hosp, Inst Life Sci & Green Dev, Cent Lab,Hebei Key Lab Canc Radiotherapy & Chemot, Baoding, Hebei, Peoples R China
出处:
ISSN:

关键词: SP1 CTBP1-AS2 miR-195-5p CEP55 Metastasis Biomarker Hepatocellular carcinoma

摘要:
As reported in many research, LncRNA CTBP1 divergent transcript (CTBP1-AS2) remarkably affects the progression of several tumors. However, the precise role and function of CTBP1-AS2 in hepatocellular carcinoma (HCC) remained unknown. We found that CTBP1-AS2 expressions were increased in HCC samples and cells. After treatment with microwave ablation (MWA), CTBP1-AS2 was distinctly up regulated in residual HCC tissues compared with HCC samples. CTBP1-AS2 was upregulated under the induction of the nuclear transcription factor SP1. As revealed by the clinical assays, high CTBP1-AS2 expression usually related to lymph node metastasis, clinical stage and weaker prognosis specific to HCC patients. Functionally, CTBP1-AS2 knockdown suppressed HCC cells in terms of the proliferation, migration, invasion, chemotherapy resistance as well as EMT progress, but promoted apoptosis. Mechanistically, CTBP1-AS2 was a sponge of miR-195-5p for elevating CEP55 expression, a target of miR-1955p, and thereby exhibited its oncogenic roles in HCC progression. Overall, an emerging regulatory mechanism of SP1/CTBP1-AS2/miR-195-5p/CEP55 axis was reported in the paper, which possibly served as a new therapeutic HCC treatment target. (c) 2020 Elsevier Inc. All rights reserved.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 3 区 生物
小类 | 3 区 生物物理 4 区 生化与分子生物学
最新[2025]版:
大类 | 4 区 生物学
小类 | 4 区 生化与分子生物学 4 区 生物物理
JCR分区:
出版当年[2020]版:
Q2 BIOPHYSICS Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY
最新[2023]版:
Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Q3 BIOPHYSICS

影响因子: 最新[2023版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者机构: [1]Chinese Peoples Liberat Army Gen Hosp, Med Sch Chinese PLA, Dept Intervent Ultrasound, 28 Fuzing Rd, Beijing 100853, Peoples R China [2]Hebei Univ, Affiliated Hosp, Dept Ultrasound, Baoding 071000, Hebei, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [1]Chinese Peoples Liberat Army Gen Hosp, Med Sch Chinese PLA, Dept Intervent Ultrasound, 28 Fuzing Rd, Beijing 100853, Peoples R China [*1]Department of Interventional Ultrasound, Chinese PLAGeneral Hospital, Medical School of Chinese PLA, No. 28, Fuxing Road, Haidian,100853, Beijing, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:15101 今日访问量:2 总访问量:962 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北大学附属医院 技术支持:重庆聚合科技有限公司 地址:保定市莲池区裕华东路212号